Publication

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas.

Journal Paper/Review - Sep 28, 2022

Units
PubMed
Doi
Contact

Citation
Weber L, Padevit L, Müller T, Velz J, Vasella F, Voglis S, Gramatzki D, Weller M, Regli L, Sarnthein J, Neidert M. Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas. Front Oncol 2022; 12:959072.
Type
Journal Paper/Review (English)
Journal
Front Oncol 2022; 12
Publication Date
Sep 28, 2022
Issn Print
2234-943X
Pages
959072
Brief description/objective

Maximum safe resection followed by chemoradiotherapy as current standard of care for WHO grade III and IV gliomas can be influenced by the occurrence of perioperative adverse events (AE). The aim of this study was to determine the association of AE with the timing and choice of subsequent treatments as well as with overall survival (OS).